DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 1 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,000 | +101.7% | 9,721 | +99.2% | 0.00% | – |
| Q2 2023 | $59,000 | +59.5% | 4,881 | +74.1% | 0.00% | – |
| Q1 2023 | $37,000 | -60.2% | 2,804 | -35.4% | 0.00% | – |
| Q4 2022 | $93,000 | +210.0% | 4,339 | +187.9% | 0.00% | – |
| Q3 2022 | $30,000 | +36.4% | 1,507 | +18.1% | 0.00% | – |
| Q2 2022 | $22,000 | -12.0% | 1,276 | -49.8% | 0.00% | – |
| Q1 2022 | $25,000 | -54.5% | 2,542 | -23.1% | 0.00% | – |
| Q4 2021 | $55,000 | +66.7% | 3,305 | +140.2% | 0.00% | – |
| Q3 2021 | $33,000 | – | 1,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |